|
[1]
|
Prince, L.A., Mann, D. and Reilly, T. (2006) Creutzfeldt-Jakob Disease: An Emergency Department Presentation of a Rare Disease. Journal of Emergency Medicine, 31, 41-44. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Krasnianski, A., Kaune, J., Jung, K., et al. (2014) First Symptom and Initial Diagnosis in Sporadic CJD Patients in Germany. Journal of Neurology, 261, 1811-1817. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
李洁, 吴大方, 刘晓宇, 等. 克雅病辅助检查的研究进展[J]. 临床荟萃, 2012, 27(3): 260-263.
|
|
[4]
|
Knight, R. (2006) Creutzfeldt-Jakob Disease: A Rare Cause of Dementia in El-derly Persons. Clinical Infectious Diseases, 43, 340-346. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lee, J., Hyeon, J.W., Kim, S.Y., et al. (2015) Review: Laboratory Diagnosis and Surveillance of Creutzfeldt-Jakob Disease. Journal of Medical Virology, 87, 175-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Puoti, G., Bizzi, A., Forloni, G., et al. (2012) Sporadic Human Prion Diseases: Molecular Insights and Diagnosis. Lancet Neurology, 11, 618-628. [Google Scholar] [CrossRef]
|
|
[7]
|
王国强, 尹维民, 张微微. 克雅氏病临床诊断1例[J]. 解放军医学杂志, 2008, 33(3): 358.
|
|
[8]
|
Shiga, Y., Miyazawa, K., Sato, S., et al. (2004) Diffusion-Weighted MRI Ab-normalities as an Early Diagnostic Marker for Creutzfeldt-Jakob Disease. Neurology, 63, 443-449. [Google Scholar] [CrossRef]
|
|
[9]
|
Harrington, M.G., Merril, C.R., Asher, D.M., et al. (1986) Abnormal Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease. New England Journal of Medicine, 315, 279-283. [Google Scholar] [CrossRef]
|
|
[10]
|
Will, R.G., Alperovitch, A., Poser, S., et al. (1998) De-scriptive Epidemiology of Creutzfeldt-Jakob Disease in Six European Countries, 1993-1995. EU Collaborative Study Group for CJD. Annals of Neurology, 43, 763-767. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Collins, S.J., Mcglade, A., Boyd, A., et al. (2010) 14-3-3 Protein Detection and Sporadic CJD: The Status Quo Serves Well While Awaiting Progress. Journal of Neurology Neurosur-gery & Psychiatry, 81, 1181. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Gmitterova, K., Heinemann, U., Bodemer, M., et al. (2009) 14-3-3 CSF Levels in Sporadic Creutzfeldt-Jakob Disease Differ across Molecular Subtypes. Neurobiology of Aging, 30, 1842-1850. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Pennington, C., Chohan, G., Mackenzie, J., et al. (2009) The Role of Cerebrospinal Fluid Proteins as Early Diagnostic Markers for Sporadic Creutzfeldt-Jakob Disease. Neuroscience Letters, 455, 56-59. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Hamlin, C., Puoti, G., Berri, S., et al. (2012) A Comparison of Tau and 14-3-3 Protein in the Diagnosis of Creutzfeldt-Jakob Disease. Neurology, 79, 547-552. [Google Scholar] [CrossRef]
|
|
[15]
|
van Harten, A.C., Kester, M.I., Visser, P.J., et al. (2011) Tau and P-Tau as CSF Biomarkers in Dementia: A Meta-Analysis. Clinical Chemistry and Laboratory Medicine, 49, 353-366. [Google Scholar] [CrossRef]
|
|
[16]
|
Bahl, J.M., Heegaard, N.H., Falkenhorst, G., et al. (2009) The Diagnostic Efficiency of Biomarkers in Sporadic Creutzfeldt-Jakob Disease Compared to Alzheimer’s Disease. Neurobiology of Aging, 30, 1834-1841. [Google Scholar] [CrossRef] [PubMed]
|